Panacea Life Sciences Holdings, Inc. (OTCPK: PLSH)
Health Care · Pharmaceuticals · US
$0.09
+6.25% today · -27.3% 1Y
Panacea Life Sciences Holdings, Inc. (OTCPK: PLSH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.78M and employs 3 people.
Over the last twelve months the share price has lost 27.3%, trading between 0.02 and 0.20.
Tweenvest scores Panacea Life Sciences Holdings, Inc. across four factors: quality 31/100, value 75/100. Its strongest factor is value.
PLSH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.78M
- Revenue (TTM)
- $2.76M
- P/E
- —
- EPS
- -0.45
- Dividend yield
- —
- Beta (5Y)
- 2.53
- 52-week high
- $0.20
- 52-week low
- $0.02
- Avg volume (3M)
- —
- Shares outstanding
- 67.99M
- Employees
- 3
- Next earnings
- —
About Panacea Life Sciences Holdings, Inc.
Panacea Life Sciences Holdings, Inc. operates as an integrated research and production firm, specializing in cannabinoid and nutraceutical products across the entire supply chain, from sourcing to final sale. Its core mission is to develop and deliver natural, pharmaceutical-grade alternatives for both human and pet consumption. The company's diverse product range encompasses items such as softgels, edible gummies, liquid tinctures, sublingual tablets, and a variety of cosmetic and topical applications. In addition to these offerings, the company is involved in the personal protective equipment (PPE) market, importing and distributing hand sanitizers and masks. Panacea Life Sciences also provides white-label and contract manufacturing services to other cannabinoid companies, sells raw materials, and manages tolling arrangements. Established in 2008, the company is headquartered in Greenwood Village, Colorado.
- ISIN
- US69810P1093
- Founded
- 2008
- Listed since
- Apr 4, 2022
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Avant Brands Inc.TSX: AVNT | $5.93M | CA$0.55 | +7.84% |
| Sonoma Pharmaceuticals, Inc.NasdaqCM: SNOA | $5.89M | $1.23 | +6.03% |
| Gelteq LimitedNasdaqCM: GELS | $5.83M | $0.52 | -0.02% |
| Firebrick Pharma LimitedASX: FRE | $5.81M | AU$0.03 | +3.57% |
| Invex Therapeutics LtdASX: IXC | $5.77M | AU$0.11 | -4.35% |
| ECS Botanics Holdings LtdASX: ECS | $5.59M | AU$0.01 | -9.09% |
| Lamdong Pharmaceutical Joint Stock CompanyHNX: LDP | $5.50M | ₫7,600.00 | -1.30% |
| Lexaria Bioscience Corp.NasdaqCM: LEXX | $5.49M | $3.32 | +15.28% |
Figures last refreshed Oct 11, 2026.